VISION Technology Contributes to over 7,000 Randomizations Across the U.S. and Europe

As of today, VISION technology has now contributed to over 7,000 randomizations across the U.S. and Europe.

At just a year since its launch, VISION is already making clinical trials more accessible to all on a global scale. We’re proud of the impact our team and technology are making in advancing clinical research.

Here’s to the next 7,000 and beyond!